hc1: Funding, Investors & Team (Sep 2026)
hc1 Insights™ (hc1) is recognized as a leading provider of real-time insights and risk signals in complex laboratory data. Thousands of laboratory locations use hc1 solutions to optimize operations and make informed decisions about testing and treatment for millions of patients. Through strategic partnerships with labs and health systems, hc1's flagship solutions have proven to deliver actionable insights that increase efficiency and lower costs. hc1 remains committed to developing innovative solutions that align with their mission of ensuring the right patient receives the right test and the right prescription. For more information about hc1's successful approach, please visit www.hc1.com.
hc1 has raised $12.8M across 2 funding rounds on record, the most recent an undisclosed round of $6.3M announced in Jan 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
hc1 Company Profile and Key Stats
Latest funding round on record: Jan 2025.
hc1 Funding Rounds
hc1 raised $6.5M in an undisclosed round announced in Sep 2024.
4 months later, an undisclosed round of $6.3M was announced in Jan 2025.
hc1 Founders and Leadership Team
Contact details for the hc1 team: 1 of 1 has an email address on file.
Start 14-day free trial →hc1 Funding Compared to Other Biotechnology Startups
hc1's latest round of $6.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like hc1 in Biotechnology and Indianapolis
Companies Similar to hc1
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
hc1 Funding FAQs
What does hc1 do?
hc1 Insights™ (hc1) is recognized as a leading provider of real-time insights and risk signals in complex laboratory data. Thousands of laboratory locations use hc1 solutions to optimize operations and make informed decisions about testing and treatment for millions of patients. Through strategic partnerships with labs and health systems, hc1's flagship solutions have proven to deliver actionable insights that increase efficiency and lower costs. hc1 remains committed to developing innovative solutions that align with their mission of ensuring the right patient receives the right test and the right prescription. For more information about hc1's successful approach, please visit www.hc1.com.
How much funding has hc1 raised?
hc1 has raised $12.8M across 2 rounds on record. The most recent is an undisclosed round of $6.3M announced in Jan 2025.
When did hc1 last raise funding?
hc1's most recent funding round on record is an undisclosed round of $6.3M, announced in Jan 2025.
Who founded hc1?
FundedIQ lists Brad Bostic (Founder) at hc1.
Where is hc1 headquartered?
hc1 is based in Indianapolis, Indiana, United States.
How many employees does hc1 have?
hc1 is in the 101-250 employee band.
How does hc1's funding compare to other Biotechnology startups?
hc1's latest round of $6.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's hc1 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for hc1 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.